Headlines

OVAS

Traders Are Watching : Twenty-First Century Fox (NASDAQ:FOXA), Cliffs Natural Resources (NYSE:CLF), EMCORE (NASDAQ:EMKR), Chimera Investment Corporation (NYSE:CIM), OvaScience (NASDAQ:OVAS)

John Meady03 mins

Twenty-First Century Fox, Inc. (NASDAQ:FOXA) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a report released on Tuesday. The firm currently has a $35.30 price objective on the stock. Zacks‘s price target suggests a potential upside of 2.50% from the stock’s previous close. Twenty-First Century Fox, Inc. (NASDAQ:FOXA) belongs to…

Read More

Stocks in Focus: Lloyds Banking Group (NYSE:LYG), ServiceNow (NYSE:NOW), Cutera (NASDAQ:CUTR), Trulia (NYSE:TRLA), OvaScience, Inc. (NASDAQ:OVAS)

Ryan Holtz02 mins

Lloyds Banking Group PLC (NYSE:LYG)‘s stock had its “buy” rating restated by research analysts at Investec in a report released on Tuesday. Lloyds Banking Group plc (NYSE:LYG) belongs to Financial sector. Its net profit margin is -4.90% and weekly performance is 2.59%. On last trading day company shares ended up $5.15. Lloyds Banking Group plc…

Read More

Hot Watch List: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Enanta Pharmaceuticals (NASDAQ:ENTA), Cheesecake Factory Incorporated (NASDAQ:CAKE), Randgold Resources Limited (NASDAQ:GOLD), OvaScience, Inc. (NASDAQ:OVAS)

Ryan Holtz03 mins

On 7 AUG OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced second quarter 2014 financial results. Revenue for the three and six months ended June 30, 2014 was $4.9 million and $16.7 million, respectively.  This compares with $6.3 million and $11.4 million, respectively, in the same periods in 2013. Revenue earned in the second quarter of 2014 consists…

Read More

Investors Watch List: Johnson & Johnson (NYSE:JNJ), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), NanoString Technologies, Inc. (NASDAQ:NSTG), OvaScience (NASDAQ:OVAS), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Jason Knox02 mins

Johnson & Johnson (NYSE:JNJ) was the first major company from the drug manufacturing industry to post impressive second-quarter earnings. The NYSE ARCA Pharmaceutical Index is up almost 20.1% in the last year. So far in 2014, the index increased10%. Johnson & Johnson (NYSE:JNJ) belongs to Healthcare sector. Its net profit margin is 21.20% and weekly…

Read More

Stocks in Focus: API Technologies (NASDAQ:ATNY), Intercept Pharmaceuticals (NASDAQ:ICPT), OvaScience (NASDAQ:OVAS), Charles & Colvard Ltd. (NASDAQ:CTHR)

Jayne Crisman02 mins

API Technologies Corp. (NASDAQ:ATNY), a leading provider of high performance RF/microwave, power, and security solutions for critical and high-reliability applications, announced today the launch of configurable frequency synthesizers (Models LCFS-X), the newest addition to the Company’s line of standard RF / microwave products. API Technologies Corp. (NASDAQ:ATNY) belongs to Technology sector. Its net profit margin…

Read More

Biotech Insider Buying: OvaScience Inc (NASDAQ:OVAS), BioTime (NYSEMKT:BTX), Insys Therapeutics (NASDAQ:INSY), Novavax (NASDAQ:NVAX), ImmuCell Corporation (NASDAQ:ICCC)

Jason Knox03 mins

Ovascience Inc (NASDAQ:OVAS) major shareholder Fund L.P. Longwood bought 100,000 shares of the company’s stock on the open market in a transaction dated Friday, March 7th. The stock was purchased at an average cost of $10.00 per share, for a total transaction of $1,000,000.00. OvaScience Inc (NASDAQ:OVAS) stock performance was -2.98% in last session and…

Read More
Home